Lactoferrin: no evidence for its role in regulation of CSA production by human lymphocytes and monocytes.

Biological role of lactoferrin. Arch Dis Child (1992) 2.15

Homologous lactoferrin triggers mobilization of the myelocytic lineage of bone marrow in experimental mice. Stem Cells Dev (2013) 0.76

Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood (1998) 2.66

Hepatic receptor that specifically binds oligosaccharides containing fucosyl alpha1 leads to 3 N-acetylglucosamine linkages. Proc Natl Acad Sci U S A (1978) 1.87

The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci U S A (1989) 1.86

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood (1996) 1.78

Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood (1995) 1.75

Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ (2008) 1.58

Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). Lab Invest (1999) 1.52

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. Eur J Cancer Clin Oncol (1989) 1.48

Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci U S A (1996) 1.47

TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ (2008) 1.47

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. J Clin Oncol (1996) 1.47

SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proc Natl Acad Sci U S A (1999) 1.44

Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat Med (1998) 1.44

Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol (1989) 1.40

Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40

The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation. Haematologica (1991) 1.38

Siah-1 binds and regulates the function of Numb. Proc Natl Acad Sci U S A (2001) 1.33

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. J Clin Oncol (1998) 1.32

Sialyl- and fucosyltransferases in the biosynthesis of asparaginyl-linked oligosaccharides in glycoproteins. Mutually exclusive glycosylation by beta-galactoside alpha2 goes to 6 sialyltransferase and N-acetylglucosaminide alpha1 goes to 3 fucosyltransferase. J Biol Chem (1978) 1.30

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893). Leukemia (1997) 1.28

A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J (1997) 1.24

Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells. Leuk Lymphoma (1999) 1.16

Biosynthesis of mammalian glycoproteins. Glycosylation pathways in the synthesis of the nonreducing terminal sequences. J Biol Chem (1979) 1.13

Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy (2004) 1.09

Value of anion-gap determination in multiple myeloma. N Engl J Med (1977) 1.09

Screening for psychiatric disorders in a lymphoma out-patient population. Eur J Cancer (1992) 1.08

Co-purification of the Lewis blood group N-acetylglucosaminide alpha 1 goes to 4 fucosyltransferase and an N-acetylglucosaminide alpha 1 goes to 3 fucosyltransferase from human milk. J Biol Chem (1981) 1.07

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine. Vaccine (1997) 1.06

Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease. Vaccine (2001) 1.05

p21WAF-1 reorganizes the nucleus in tumor suppression. Proc Natl Acad Sci U S A (1998) 1.04

SIAH-1 inhibits cell growth by altering the mitotic process. Oncogene (1999) 1.03

Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. Proc Natl Acad Sci U S A (2000) 1.03

The cDNA sequence and gene analysis of the human pim oncogene. Gene (1987) 1.02

Deoxyribonucleic acid synthesis time of erythropoietic and granulopoietic cells in human beings. Nature (1966) 1.01

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group. Blood (1997) 0.99

The binding of glycoconjugates to human-milk D-galactosyltransferase. Eur J Biochem (1976) 0.98

Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study. Bone Marrow Transplant (2003) 0.97

Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol (2009) 0.96

Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev (2005) 0.95

Kinetics of lymphocytes in chronic lymphocytic leukemia. I. Equilibrium between blood and a "readily accessible pool". Blood (1973) 0.93

A calcium-dependent protein activator of guanosine 3':5'-monophosphate phosphodiesterase in bovine and rat pancreas. Isolation, properties and levels in vivo. Eur J Biochem (1977) 0.93

Human milk fucosyltransferases [proceedings]. Biochem Soc Trans (1977) 0.92

Internalization of human T lymphocyte receptors. Eur J Immunol (1987) 0.92

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant (1997) 0.91

Gastrointestinal metastases from extra-abdominal tumors. Endoscopy (1985) 0.90

Lactoferrin binding to lysozyme-treated Micrococcus luteus. Biochim Biophys Acta (1982) 0.89

Enzymatic basis for a lectin-resistant phenotype: increase in a fucosyltransferase in mouse melanoma cells. J Cell Biol (1982) 0.89

Lethal oxidative damage to human immunodeficiency virus by human recombinant myeloperoxidase. FEBS Lett (1992) 0.89

Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work. Support Care Cancer (1993) 0.88

Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats. J Virol (2000) 0.88

Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells. Ann Hematol (1993) 0.86

Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood (1993) 0.84

Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection. J Infect Dis (1996) 0.84

Tumour stimulating effects of recombinant human interleukin-6. Lancet (1994) 0.83

Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors. Br J Haematol (2001) 0.82

The potentiality of out-of-cycle acute leukemic cells to synthesize DNA. Blood (1970) 0.82

Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors. Br J Haematol (1997) 0.82

Immunological cross-reactions of alpha-lactalbumins from different species. Eur J Biochem (1975) 0.82

Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. Exp Hematol (1994) 0.82

Cell adhesion mediated by a purified fucosyltransferase. Proc Natl Acad Sci U S A (1983) 0.82

TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia. Leuk Lymphoma (1998) 0.82

Cellular uptake, cytotoxicity, and transport kinetics of anthracyclines in human sensitive and multidrug-resistant K562 cells. Biochem Pharmacol (1996) 0.82

Removal of tumour cells from bone marrow: overview. Eur J Cancer Clin Oncol (1989) 0.81

Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. Blood (1996) 0.81

Interaction between lysozyme and some lactoferrin complex in human milk. Arch Int Physiol Biochim (1974) 0.81

Involvement of histidine-32 in the biological activity of alpha-lactalbumin. Biochemistry (1979) 0.81

Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation. Bone Marrow Transplant (2000) 0.81

Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantation. Leuk Lymphoma (1998) 0.81

Purification of mammalian glycosyltransferases. Methods Enzymol (1982) 0.81

Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model. Exp Hematol (1991) 0.81

Identification of a 130 Kda bcr related gene product. Oncogene (1989) 0.80

Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent. J Natl Cancer Inst (1981) 0.80

Intermittent dose schedule of mitomycin C (NSC-26980) in solid tumors. Cancer Chemother Rep (1972) 0.80

Chemotherapy of adult acute lymphoblastic leukaemia. Baillieres Clin Haematol (1991) 0.80

Human suppressor factors constitutively produced by T-T cell hybridomas: functional and biochemical characterization. Hybridoma (1989) 0.80

Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells. Cytotherapy (2003) 0.80

Receptors on hepatocytes that bind ligands containing fucosyl alpha 1,3 N-acetylglucosamine linkages. Birth Defects Orig Artic Ser (1980) 0.79

Nitration of tyrosyl residues in human alpha-lactalbumin. Effect on lactose synthase specifier activity. Eur J Biochem (1975) 0.79

Lactoferrin: its role as a regulator of human granulopoiesis? Ann N Y Acad Sci (1985) 0.79

Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol (1985) 0.79

Cyclic nucleotide phosphodiesterases from rat pancreas: differential regulation by a calcium-dependent activator protein [proceedings]. Biochem Soc Trans (1977) 0.79